Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2015

Open Access 01-12-2015 | Research

In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial

Authors: Jayanta T. Mukherjee, Joni R. Beshansky, Robin Ruthazer, Hadeel Alkofide, Madhab Ray, David Kent, Warren J. Manning, Gordon S. Huggins, Harry P. Selker;

Published in: Cardiovascular Ultrasound | Issue 1/2015

Login to get access

Abstract

Background

In patients with acute coronary syndrome (ACS), reduced left ventricular ejection fraction (LVEF) is a known marker for increased mortality. However, the relationship between LVEF measured during index ACS hospitalization and mortality and heart failure (HF) within 1 year are less well-defined.

Methods

We performed a retrospective analysis of 445 participants in the IMMEDIATE Trial who had LVEF measured by left ventriculography or echocardiogram during hospitalization.

Results

Adjusting for age and coronary artery disease (CAD) history, lower LVEF was significantly associated with 1-year mortality or hospitalization for HF. For every 5 % LVEF reduction, the hazard ratio [HR] was 1.26 (95 % CI 1.15, 1.38, P < 0.001). Participants with LVEF < 40 % had higher hazard of 1-year mortality or HF hospitalization than those with LVEF > 40 (HR 3.59; 95 % CI 2.05, 6.27, P < 0.001). The HRs for the association of LVEF with the study outcomes were similar whether measured by left ventriculography or by echocardiography, (respectively, HR 1.32; 95 % CI 1.15, 1.51 and 1.21; 95 % CI 1.106, 1.35, interaction P = 0.32) and whether done within 24 h or not within 24 h (respectively, HR 1.28; 95 % CI 1.10, 1.50 and 1.23; 95 % CI 1.10, 1.38, interaction P = 0.67).

Conclusions

Among patients with ACS, lower in-hospital LVEF is associated with increased 1-year mortality or hospitalization for HF, regardless of the method or timing of the LVEF assessment. This has prognostic implications for clinical practice and suggests the possibility of using various methods of LVEF determination in clinical research.
Appendix
Available only for authorised users
Literature
1.
go back to reference American Heart Association. Heart and stroke statistics. Circulation. 2013;127(1):e6–245.CrossRef American Heart Association. Heart and stroke statistics. Circulation. 2013;127(1):e6–245.CrossRef
2.
go back to reference Burns RJ, Gibbons RJ, Yi Q, et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002;39:30–6.CrossRefPubMed Burns RJ, Gibbons RJ, Yi Q, et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002;39:30–6.CrossRefPubMed
3.
go back to reference Zaret BL, Wackers FJ, Terrin ML, et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: Results of thrombolysis in myocardial infarction (timi) phase ii study. The timi study group. J Am Coll Cardiol. 1995;26:73–9.CrossRefPubMed Zaret BL, Wackers FJ, Terrin ML, et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: Results of thrombolysis in myocardial infarction (timi) phase ii study. The timi study group. J Am Coll Cardiol. 1995;26:73–9.CrossRefPubMed
4.
go back to reference Nicolosi GL, Latini R, Marino P, et al. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the gissi-3 trial. Eur Heart J. 1996;17:1646–56.CrossRefPubMed Nicolosi GL, Latini R, Marino P, et al. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the gissi-3 trial. Eur Heart J. 1996;17:1646–56.CrossRefPubMed
5.
go back to reference Nishimura RA, Reeder GS, Miller F, et al. Prognostic value of predischarge two-dimensional echocardiogram after acute myocardial-infarction. Am J Cardiol. 1984;53:429–32.CrossRefPubMed Nishimura RA, Reeder GS, Miller F, et al. Prognostic value of predischarge two-dimensional echocardiogram after acute myocardial-infarction. Am J Cardiol. 1984;53:429–32.CrossRefPubMed
6.
go back to reference Penco M, Sciomer S, Vizza CD, et al. Clinical impact of echocardiography in prognostic stratification after acute myocardial infarction. Am J Cardiol. 1998;81:17G–20.CrossRefPubMed Penco M, Sciomer S, Vizza CD, et al. Clinical impact of echocardiography in prognostic stratification after acute myocardial infarction. Am J Cardiol. 1998;81:17G–20.CrossRefPubMed
7.
go back to reference Daneault B, Genereux P, Kirtane AJ, et al. Comparison of three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40 % versus >/= 40 % (from the horizons-ami trial). Am J Cardiol. 2013;111:12–20.CrossRefPubMed Daneault B, Genereux P, Kirtane AJ, et al. Comparison of three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40 % versus >/= 40 % (from the horizons-ami trial). Am J Cardiol. 2013;111:12–20.CrossRefPubMed
8.
go back to reference Selker HP, Beshansky JR, Sheehan PR, et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: The immediate randomized controlled trial. JAMA t. 2012;307:1925–33.CrossRef Selker HP, Beshansky JR, Sheehan PR, et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: The immediate randomized controlled trial. JAMA t. 2012;307:1925–33.CrossRef
9.
go back to reference Selker HP, Udelson JE, Massaro JM, et al. One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (gik) in patients with suspected acute coronary syndromes (from the immediate trial). Am J Cardiol. 2014;113:1593–776.CrossRef Selker HP, Udelson JE, Massaro JM, et al. One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (gik) in patients with suspected acute coronary syndromes (from the immediate trial). Am J Cardiol. 2014;113:1593–776.CrossRef
10.
go back to reference Selker HP, Beshansky JR, Griffith JL, et al. Study design for the immediate myocardial metabolic enhancement during initial assessment and treatment in emergency care (immediate) trial: a double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. Am Heart J. 2012;163:315–22.CrossRefPubMedPubMedCentral Selker HP, Beshansky JR, Griffith JL, et al. Study design for the immediate myocardial metabolic enhancement during initial assessment and treatment in emergency care (immediate) trial: a double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. Am Heart J. 2012;163:315–22.CrossRefPubMedPubMedCentral
11.
go back to reference Beshansky JR, Sheehan PR, Klima KJ, et al. A community consultation survey to evaluate support for and success of the IMMEDIATE trial. Clinical Trials. 2014;11:178–86.CrossRefPubMedPubMedCentral Beshansky JR, Sheehan PR, Klima KJ, et al. A community consultation survey to evaluate support for and success of the IMMEDIATE trial. Clinical Trials. 2014;11:178–86.CrossRefPubMedPubMedCentral
12.
go back to reference Jedrzkiewicz S, Goodman SG, Yan RT, et al. Evaluation of left ventricular ejection fraction in non-st-segment elevation acute coronary syndromes and its relationship to treatment. Am Heart J. 2010;159:605–11.CrossRefPubMed Jedrzkiewicz S, Goodman SG, Yan RT, et al. Evaluation of left ventricular ejection fraction in non-st-segment elevation acute coronary syndromes and its relationship to treatment. Am Heart J. 2010;159:605–11.CrossRefPubMed
13.
go back to reference Hernandez AF, Velazquez EJ, Solomon SD, et al. Left ventricular assessment in myocardial infarction - the valiant registry. Arch Intern Med. 2005;165:2162–9.CrossRefPubMed Hernandez AF, Velazquez EJ, Solomon SD, et al. Left ventricular assessment in myocardial infarction - the valiant registry. Arch Intern Med. 2005;165:2162–9.CrossRefPubMed
14.
go back to reference Santolucito PA, Tighe DA, Lessard D, et al. Changing trends in the evaluation of ejection fraction in patients hospitalized with acute myocardial infarction: The worcester heart attack study. Am Heart J. 2008;155:485–93.CrossRefPubMedPubMedCentral Santolucito PA, Tighe DA, Lessard D, et al. Changing trends in the evaluation of ejection fraction in patients hospitalized with acute myocardial infarction: The worcester heart attack study. Am Heart J. 2008;155:485–93.CrossRefPubMedPubMedCentral
15.
go back to reference Lopez-Jimenez F, Goraya TY, Hellermann JP, et al. Measurement of ejection fraction after myocardial infarction in the popoulation. Chest. 2004;125:397–403.CrossRefPubMed Lopez-Jimenez F, Goraya TY, Hellermann JP, et al. Measurement of ejection fraction after myocardial infarction in the popoulation. Chest. 2004;125:397–403.CrossRefPubMed
16.
go back to reference Lee JH, Bae MH, Yang DH, et al. Prognostic value of the age, creatinine, and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction. Am J Cardiol. 2015;115(9):1167–73.CrossRefPubMed Lee JH, Bae MH, Yang DH, et al. Prognostic value of the age, creatinine, and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction. Am J Cardiol. 2015;115(9):1167–73.CrossRefPubMed
17.
go back to reference Mancini GB, Hartigan PM, Bates ER, et al. Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial. Am Heart J. 2013;166:481–7.CrossRefPubMed Mancini GB, Hartigan PM, Bates ER, et al. Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial. Am Heart J. 2013;166:481–7.CrossRefPubMed
Metadata
Title
In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial
Authors
Jayanta T. Mukherjee
Joni R. Beshansky
Robin Ruthazer
Hadeel Alkofide
Madhab Ray
David Kent
Warren J. Manning
Gordon S. Huggins
Harry P. Selker;
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2015
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/s12947-016-0068-1

Other articles of this Issue 1/2015

Cardiovascular Ultrasound 1/2015 Go to the issue